Increasing Prevalence Of Autoimmune Disorders Driving Growth In The Market: Key Factor Driving The Growth In The Eczema Market

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Expected Eczema Market Size During the Forecast Period?
The growth of the eczema market size has been vigorous in the past few years. It's projected to escalate from a worth of $16.41 billion in 2024 to a value of $17.81 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. A surge in the prevalence of autoimmune disorders, an increase in eczema incidence, a rise in authorization from regulatory bodies, growing instances of air pollutants, and an escalating load of allergic reactions contribute to the market's growth during the historical period.

In the upcoming years, the eczema market is predicted to experience robust expansion, reaching a worth of $24.35 billion in 2029 with an 8.1% compound annual growth rate (CAGR). This growth during the forecast horizon can be ascribed to the growing demand for atopic dermatitis treatments, heightened operational activities, increased eczema awareness and incorporation of biologics, along with a rise in the usage of telemedicine platforms. The period is also likely to witness major trends like strategic partnerships, the rise of new therapies, the introduction of injectable drugs, and the advent of personalized medicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21179

What Are the High-Growth Segments in the Eczema Market?
The eczema market covered in this report is segmented -

1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types
2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy
3) By Age Group: Children, Adults, Elderly
4) By End User: Hospitals Or Clinics, Dermatology Centers, Home Care, Pharmacies

Subsegments:
1) By Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies
2) By Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses
3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors
4) By Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21179&type=smp

What Key Drivers Are Expected to Influence Future Eczema Market Growth?
The escalating rate of autoimmune disorders is anticipated to stimulate the expansion of the eczema market. Autoimmune disorders are conditions where the body's immune system erroneously attacks its healthy cells, tissues, or organs, resulting in inflammation and damage. The escalating rate of autoimmune disorders is connected to genetic susceptibility, environmental influences, infections, changes in diet, and lifestyle factors such as stress and exposure to pollutants. Autoimmunity diseases like psoriasis, lupus, and rheumatoid arthritis are associated with deregulated immune responses, increasing the individual's vulnerability to eczema and other inflammatory skin diseases. For example, according to Versorgungsatlas.de, a Germany-based organization, in November 2024, it was noted that out of 73,241,305 insured individuals in 2022, 6,304,340 were identified with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. As a result, the escalating rate of autoimmune disorders is fuelling eczema market growth.

Which Companies Hold the Largest Share Across Different Eczema Market Segments?
Major companies operating in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc

What Trends Are Driving Growth in The Eczema Market?
The emphasis in the eczema market by leading companies is on generating novel products like eczema care creams, with the aim of improving the effectiveness of treatment and satisfying the need for enhanced skincare solutions. Providing hydration, protection, and relief, eczema care creams are specifically crafted to cater to skin affected by eczema, thereby helping to alleviate dryness, itching, and inflammation. Illustratively, Dove, a personal care brand from the UK, introduced a new Eczema Care line for infants in September 2024. This line includes the Baby Dove Eczema Care Soothing Bath Treatment and Baby Dove Eczema Care Cream. The Baby Dove Eczema Care products are imbued with distinct features created for infants suffering from eczema. Notably, these goods are composed of 100% skin-natural nutrients, confirming their mildness on sensitive skin. They also include colloidal oatmeal at 1.0%, a crucial component for soothing irritation and preserving skin moisture.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/eczema-global-market-report

What Are the Emerging Geographies for The Eczema Market Growth?
North America was the largest region in the eczema market in 2024. The regions covered in the eczema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Eczema Market?
2. What is the CAGR expected in the Eczema Market?
3. What Are the Key Innovations Transforming the Eczema Industry?
4. Which Region Is Leading the Eczema Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.